Nicholas Larus-Stone is Benchling’s Head of AI and coauthor of a new benchmarking study putting large language models (LLMs) like Claude and ChatGPT to work redesigning wet lab protocols.
The models did just fine, but didn’t blow the Benchling team away. “They can certainly be helpful at certain biological tasks, but they've by no means solved some of the kind of biology problems that people really care about,” Larus-Stone said.
That said, he believes that pharmaceutical companies should be spending more on AI usage. That’s just one of several spicier takes we got into in our conversation.
Listen for more of Larus-Stone’s thoughts on why benchmarking LLMs is important, how open-source models can be competitive against proprietary ones, how he has fostered cross-pollination between software engineers and scientists by founding Bits in Bio, and whether he likes the term “TechBio.”
Show Notes
Benchling’s Bench-Bench protocol study white paper
Podden och tillhörande omslagsbild på den här sidan tillhör
Andrew P. Han. Innehållet i podden är skapat av Andrew P. Han och inte av,
eller tillsammans med, Poddtoppen.